| http://www.w3.org/ns/prov#value | - Therefore we obtained all relevant auxiliary information available for trials with a duration of dual antiplatelet therapy of less than six months, such as the information stated in the protocol and the percentage of patients reporting the use of dual antiplatelet therapy at relevant time points.
|
